FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

24556411000001109: Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Jun 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1733341000001116 Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1733351000001118 Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) Is a Posaconazole 100mg gastro-resistant tablets true Inferred relationship Existential restriction modifier
Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) Has active ingredient Posaconazole true Inferred relationship Existential restriction modifier
Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient Posaconazole true Inferred relationship Existential restriction modifier
Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) Has dispensed dose form Gastro-resistant oral tablet true Inferred relationship Existential restriction modifier
Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) Is a Noxafil true Inferred relationship Existential restriction modifier
Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) Has manufactured dose form Gastro-resistant oral tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) 24 tablet 2 x 12 tablets Has AMP True Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) Inferred relationship Existential restriction modifier
Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) 96 tablet 8 x 12 tablets Has AMP True Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start